Bristol-Myers Squibb Company (BMY) Revenue 2016–2025
Bristol-Myers Squibb Company (BMY) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$48.2BFY2025 · since FY2016: $19.4B → $48.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.2B | -0.2% |
| FY2024 | $48.3B | +7.3% |
| FY2023 | $45.0B | -2.5% |
| FY2022 | $46.2B | -0.5% |
| FY2021 | $46.4B | +9.1% |
| FY2020 | $42.5B | +62.6% |
| FY2019 | $26.1B | +15.9% |
| FY2018 | $22.6B | +8.6% |
| FY2017 | $20.8B | +6.9% |
| FY2016 | $19.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice